Hepatitis C virus and blood vial

HCV Video Perspectives

Healio spoke with experts in HCV about treatment, the importance of screening, transplantation of HCV-positive organs, how the COVID-19 pandemic has affected hepatitis C elimination goals and challenges in the field.

Jordan Feld, MD, MPH

Jordan Feld, MD, MPH, associate professor of medicine at the University of Toronto and clinician-scientist at the Toronto Center for Liver Disease of Toronto General Hospital, discussed:

  • HCV-related highlights from the 2020 Liver Meeting, including results from the MINMON and HERO studies;
  • How the COVID-19 pandemic has impacted the hepatitis C elimination goals – “we’re going to have to put our foot back on the gas and really accelerate our screening efforts and treatment efforts;”
  • How more laboratory testing due to COVID-19 could possibly be leveraged to increase screening for hepatitis C, and possible opportunities to couple COVID-19 testing with hepatitis C testing;
  • The need for better follow-up for people at risk for re-infection and the need for better models to predict who is at risk of developing liver cancer in patients with cirrhosis;
  • Greatest challenges in HCV today: the need for a vaccine and long-acting injectables; and
  • His hope that after the COVID-19 pandemic is under control, the HCV community will come back to elimination efforts “with renewed vigor.”
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.